CBOA
EW icon

Commonwealth Bank of Australia’s Edwards Lifesciences EW Stock Holding History

Commonwealth Bank of Australia’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,619
Closed -$527K – 333
2019
Q2 		$527K Buy
8,619
+1,884
+28% +$114K 0.01% 718
2019
Q1 		$428K Sell
6,735
-160,827
-96% -$9.18M ﹤0.01% 668
2018
Q4 		$8.55M Sell
167,562
-141,852
-46% -$7.18M 0.09% 140
2018
Q3 		$18M Buy
309,414
+2,439
+0.8% +$119K 0.17% 92
2018
Q2 		$14.9M Buy
306,975
+252
+0.1% +$11.8K 0.15% 101
2018
Q1 		$14.3M Sell
306,723
-506,919
-62% -$22M 0.15% 111
2017
Q4 		$30.6M Buy
813,642
+616,737
+313% +$22.6M 0.3% 71
2017
Q3 		$7.08M Buy
196,905
+16,416
+9% +$626K 0.07% 192
2017
Q2 		$7.11M Sell
180,489
-228,651
-56% -$8.35M 0.07% 179
2017
Q1 		$12.8M Buy
409,140
+80,511
+24% +$2.52M 0.14% 112
2016
Q4 		$10.3M Buy
328,629
+187,728
+133% +$6.08M 0.13% 123
2016
Q3 		$5.66M Sell
140,901
-21,906
-13% -$825K 0.07% 167
2016
Q2 		$5.41M Buy
162,807
+26,175
+19% +$896K 0.06% 175
2016
Q1 		$4.02M Buy
136,632
+237
+0.2% +$6.54K 0.05% 215
2015
Q4 		$3.59M Buy
136,395
+315
+0.2% +$8.18K 0.05% 215
2015
Q3 		$3.22M Buy
136,080
+5,616
+4% +$136K 0.04% 230
2015
Q2 		$3.1M Buy
130,464
+18,888
+17% +$426K 0.04% 213
2015
Q1 		$2.65M Buy
111,576
+107,976
+2,999% +$2.42M 0.04% 252
2014
Q4 		$76K Hold
3,600
– – ﹤0.01% 607
2014
Q3 		$61K Hold
3,600
– – ﹤0.01% 727
2014
Q2 		$52K Sell
3,600
-256,032
-99% -$3.47M ﹤0.01% 747
2014
Q1 		$3.21M Buy
259,632
+214,632
+477% +$2.48M 0.02% 548
2013
Q4 		$493K Buy
45,000
+3,600
+9% +$40.6K ﹤0.01% 1014
2013
Q3 		$480K Hold
41,400
– – ﹤0.01% 984
2013
Q2 		$464K Buy
+41,400
New +$490K ﹤0.01% 968

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Commonwealth Bank of Australia's EW Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Edwards Lifesciences (EW) in Q3 2019, closing a stake of 8,619 shares — an estimated $527K sold.

Commonwealth Bank of Australia first reported a position in EW in Q2 2013 and held it in 25 quarters. The position peaked at $30.6M in Q4 2017. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Edwards Lifesciences position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 8,619 Edwards Lifesciences shares in Q3 2019, an estimated $527K.
  • Commonwealth Bank of Australia first reported a position in Edwards Lifesciences in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Edwards Lifesciences position peaked at $30.6M in Q4 2017.
  • 965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.